Track topics on Twitter Track topics that are important to you
Here are the most relevant search results for "Therapure Biopharma" found in our extensive news archives from over 250 global news sources.
In addition to our news stories we have dozens of PubMed Articles about Therapure Biopharma for you to read. Along with our medical data and news we also list Therapure Biopharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Therapure Biopharma Companies for you to search.
Therapure Biopharma Inc. announces that it is the recipient of the Mississauga Board of Trade’s (MBOT’s) 2017 Business Awards of Excellence. Hundreds of members and honoured guests were on hand for this sold out event, held at the Mississauga Convention Centre on Thursday, November 16, 2017. In winning the MBOT award, Therapure demonstrated: ...
KBI Biopharma is a CMO focused exclusively on biologics. Bernardo Estupinan-Gaisbauer, Vice President – Business Development at KBI Biopharma, discusses their strategy for partnering, and the challenges of staying competitive in the CMO sector.
In between NIBRT site tours and tax workshops in Dublin Castle, Biopharma-Reporter is covering BioPharma Ambition on the Emerald Isle.
What trends will shape the biopharma industry in 2018? BioPharma Dive's editors took a stab at predicting how the year may unfold for AI, oncology and neuroscience.
NEW YORK, NY / ACCESSWIRE / January 11, 2018 / Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Array Biopharma, Inc. ("Array Biopharma" or the "Company") (NASDAQ:...
Galena Biopharma is one of 116 publicly-traded companies in the "Pharmaceuticals" industry, but how does it compare to its peers? We will compare Galena Biopharma to similar companies based on the strength of its analyst recommendations, dividends, profitability, risk, institutional ownership, earnings and valuation. 20.5% of Galena Biopharma shares are owned by institutional investors.
American College of Cardiology CEO Shalom “Shal” Jacobovitz is leav
Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: (Senior) Manager, Regulatory Operations – Biopharma .MA-Waltham, Direct-hire opportunity for a Manager or Associate Director of Regulatory Operations! This is a newly created role with a growing biotech … Continue reading → Cet article #jobs #lifescience (Sen...
A newly published SAFE-BioPharma Trust List vastly improves workflows involving sensitive and proprietary electronic documents exchanged between the US and the EU. When incorporated into the EU framework, the Trust List can allow European Relying Parties to validate digital signatures issued by SAFE-BioPharma certified providers in the same way they can va...
TEL-AVIV, Israel and RALEIGH, N.C., 2017-11-08 15:15 CET (GLOBE NEWSWIRE) -- RedHill Biopharma Ltd. (NASDAQ:RDHL) (Tel-Aviv Stock Exchange:RDHL) ("RedHill" or the "Company"), a specialty biopharmac...
An initial public offering brought in $66.2 million for Cue BioPharma. -More-
Biopharma companies are positively giddy about the new tax law. Here's why.
NewsThe University of Nebraska Medical Center and Hemispherx Biopharma, Inc. are joining forces to take on pancreatic cancer, one of the most deadly forms of cancer.
Vitality Biopharma Completes Pivotal GMP Manufacturing Agreements for Cannabinoid Pharmaceuticals / R&D operations in California registered with DEA to enable production of new class of cannabinoid pharmaceuticals
LOS ANGELES, CA -- (Marketwired) -- 11/01/17 -- Vitality Biopharma, Inc. (OTCQB: VBIO) ("Vitality Biopharma," "Vitality," or the "Company") a corporation dedicated to the development of cannabinoi...
In a second significant in-licensing deal this month, Shanghai, China-based I-Mab Biopharma receives…
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Nov. 13, 2017 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced the submission of a New Drug Application...
PDL BioPharma today officially announced it will no longer pursue its proposed acquisition of US modified-release…
MorphoSys has entered into an agreement with Shanghai-based I-Mab Biopharma granting the latter an exclusive…
Biopharma can find plenty to celebrate — and a few things to despair — in the new Republican plan to rewrite the tax code.
NewsCara Therapeutics, partnering with Enteris BioPharma, has initiated the Phase One clinical trial of its oral Korsuva in patients with chronic liver disease. Enteris will continue to manufacture the oral tablet formulation through Phase Two.
DUBLIN and HERTFORDSHIRE, England and PITTSBURGH, Jan. 29, 2018 /PRNewswire/ -- Theravance Biopharma, Inc. (NASDAQ: TBPH) ("Theravance Biopharma") and Mylan N.V. (NASDAQ, TASE: MYL) ("Mylan") today announced that the U.S. Food and Drug...
US-based company Cue Biopharma has entered a strategic research collaboration and licence agreement with Merck to focus on the development...Read More... The post Cue Biopharma and Merck to develop biologics for autoimmune diseases appeared first on Pharmaceutical Technology.
In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with William J Newell, Chief Executive Officer at Sutro Biopharma, a biopharma drug development firm They discuss the company's: • origins and business model • collaborations • platform technology, how it works and its advantages over its competitors’ platforms • plans for the future
GT Biopharma has completed dosing patients in a Phase l trial of GTP-004 for the treatment of myasthenia gravis symptoms....Read More... The post GT Biopharma ends dosing in Phase l trial of GTP-004 appeared first on Drug Development Technology.
Each month, biopharma executives share insights about leadership and management — and tips for thriving in a roller-coaster industry.